Acquisition of a new primary healthcare centre

RNS Number : 5313L

The MedicX Fund Limited

19 April 2018

 

For immediate release

19 April 2018

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Acquisition of a new primary healthcare centre 

MedicX Fund Limited, (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom and Ireland, is pleased to announce that it has contracted to acquire, by way of forward funding, a new primary healthcare medical centre in Peterborough. The property is due to be completed in April 2019.

The completed development will be let to the GPs of the Nightingale Medical Practice. All leases will be for a term of 20 years from practical completion. The completed property will consist of c.900 m² with 3 yearly reviews to market rent. The total acquisition price including costs is expected to be £3.2 million.

MedicX Fund's total property portfolio now comprises 154 properties throughout the United Kingdom and Ireland of which 150 are operational and let, with four under construction. The annualised rent roll for all properties is now £40.8 million.

Medicx Fund continues to be in active dialogue on a number of investment opportunities in both the UK and Republic of Ireland where it continues to take a disciplined approach to asset selection.  

- End -

For further information please contact:

Octopus Healthcare Adviser Ltd                                     [phone]

Octopus Healthcare                                                      [phone]

Mike Adams, Executive Chairman

Buchanan                                                                    [phone]

Charles Ryland/Henry Wilson

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 154 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over £1.2 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages £7.7 billion of funds for more than 50,000 retail and institutional investors as well as supplying energy to more than 180,000 customers.

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

The Company's Legal Entity Identifier is 2138008POF35FTNFCB25

 

END

 

 

MSCQKLFFVZFLBBZ